ENTERO — Entero Healthcare Solutions Income Statement
0.000.00%
Last trade - 00:00
- IN₹45.54bn
- IN₹49.75bn
- IN₹33.00bn
- 21
- 15
- 54
- 15
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 13,496 | 17,797 | 25,221 | 33,002 |
Cost of Revenue | ||||
Gross Profit | 1,085 | 1,382 | 2,056 | 2,641 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 13,376 | 17,745 | 25,174 | 32,604 |
Operating Profit | 120 | 52.7 | 46.8 | 398 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 38.7 | -108 | -198 | -36.9 |
Provision for Income Taxes | ||||
Net Income After Taxes | 12.9 | -154 | -294 | -111 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 9.44 | -155 | -299 | -116 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 9.44 | -155 | -299 | -116 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.217 | -3.57 | -6.88 | -2.66 |
Dividends per Share |